Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RSPH vs. FTXH: which is better?

Bottom line

RSPH vs FTXH: the short answer

RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are quite different portfolios: only about 23% of their top holdings (by weight) are shared.

RSPH is cheaper at 0.4% vs 0.6% — a difference of $20 a year per $10,000 invested.

Over five years, FTXH returned +6.5% a year vs +4.7% for RSPH.

Updated Nov 19, 2026

RSPH vs FTXH side by side

RSPHFTXH
TypeETFETF
Fund familyInvescoFirst Trust
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.4%0.6%
Annual cost per $10k$40$60
10-yr cost on $10k (prospectus)$505—
Max front loadNoneNone
12b-1 fee—0%
1-yr return+9.3%+24.0%
5-yr return (annualized)+4.7%+6.5%
10-yr return (annualized)+8.2%—
Best quarter+17.5%+18.3%
Worst quarter−14.3%−17.4%
Net assets (fund)$766.9M$36.2M
Number of holdings6351
Portfolio turnover24%35%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRSPHFTXHDifference
2025+9.3%+24.0%−14.7%
2024−0.8%+3.0%−3.8%
2023+3.9%−1.4%+5.4%
2022−9.2%+2.5%−11.8%
2021+23.0%+6.1%+16.9%
2020+18.9%+10.9%+8.0%
2019+25.3%+22.4%+3.0%
2018−0.3%−8.4%+8.0%
2017+23.4%+18.8%+4.6%

Source: Fund prospectus bar charts

Holdings overlap

7 of RSPH's top 25 holdings also appear in FTXH's top 25.

Shared top holdings
HoldingRSPHFTXH
Regeneron Pharmaceuticals, Inc.1.96%2.72%
Charles River Laboratories International, Inc.1.93%1.49%
Bristol-Myers Squibb Co.1.82%6.29%
Amgen Inc.1.77%3.18%
Incyte Corp.1.76%2.39%
AbbVie Inc.1.73%7.39%
Viatris Inc.1.72%3.62%

Source: SEC Form N-PORT

RSPH top 10

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Regeneron Pharmaceuticals, Inc. — 1.96%
  5. Mettler-Toledo International Inc. — 1.94%
  6. Charles River Laboratories International, Inc. — 1.93%
  7. Veeva Systems Inc. — 1.93%
  8. DaVita Inc. — 1.87%
  9. Moderna, Inc. — 1.85%
  10. Thermo Fisher Scientific Inc. — 1.84%

FTXH top 10

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Merck & Company Inc — 7.07%
  4. Johnson & Johnson — 6.96%
  5. Bristol-myers Squibb Company — 6.29%
  6. Biogen Inc — 3.84%
  7. Viatris Inc — 3.62%
  8. Cardinal Health Inc — 3.53%
  9. Vertex Pharmaceuticals Inc — 3.41%
  10. Amgen Inc — 3.18%

FAQ

What is the difference between RSPH and FTXH?
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are quite different portfolios: only about 23% of their top holdings (by weight) are shared. RSPH is cheaper at 0.4% vs 0.6% — a difference of $20 a year per $10,000 invested.
Which is cheaper, RSPH or FTXH?
RSPH has the lower expense ratio (0.4%).
Should I own both RSPH and FTXH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.